Fresh2 Group Limited
Fresh2 Group Limited (FRES) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FRES · as of Jun 9, 2026
Key Statistics
Explore Fresh2 Group Limited Data
fres stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
fres competitorsFRES
ASLN
CUTR
EIGRQ
MTP
NTBLStock Performance
Full HistoryAbout Fresh2 Group Limited
Fresh2 Group Limited a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science C…
what is fresh2 group limited · fres stock overview · fresh2 group limited company profile · who is fresh2 group limited ceo · fres NASDAQ · fresh2 group limited headquarters · fresh2 group limited business segments
About Stock Overview & Key Data
Fresh2 Group Limited (FRES) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 30, 2020. As of the latest trading session, FRES stock price is $0.85, with a market capitalization of $2.1M. The stock has returned -82.57% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Fresh2 Group Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Fresh2 Group Limited reported revenue of $12.0M and net income of -$101.9M. For detailed data — including Fresh2 Group Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fresh2 Group Limited (FRES) stock price is $0.85. The stock is traded on NASDAQ under the ticker symbol FRES. The 52-week range is $0.73 – $9.00.